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Abstract
Aim: Apelin has important effects on the circulatory system and heart. The main aim of this study was to investigate the effects 
of apelin-13 on the contraction induced by norepinephrine (NE), and the endothelium-independent relaxation induced by sodium 
nitroprusside (SNP) in human internal mammary artery (IMA) obtained from patients undergoing coronary artery bypass grafting 
(CABG) surgery.
Material and Methods: IMA rings, obtained from patients undergoing CABG surgery, were suspended in isolated tissue baths 
containing Krebs-Henseleit solution, which were continuously gassed with 95% O2 and 5% CO2 at 37°C. 
Results: The IMA rings were pre-contracted with increasing concentrations of norepinephrine (NE 10-9–10-4 mol/l) and the 
endothelium-independent relaxation responses to sodium nitroprusside (SNP)  were studied. Apelin-13 (10 μM) caused a dose-
dependent relaxation in NE pre-contracted IMA rings. Apelin also facilitated the endothelium-independent relaxation induced by 
SNP.
Conclusion: According to the results, apelin facilitated the endothelium-independent relaxation and  inhibited the contractile activity 
of IMA. These results suggest that apelin may be a physiological agent against the deterioration of vascular elasticity caused by 
endothelial damage especially in atherosclerotic cardiac patients and hypertensive patients.
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INTRODUCTION
Apelin was isolated from the bovine stomach extracts 
as an endogenous ligand of the APJ receptor, which is a 
member of the G-protein-bound receptor family, in 1998 
(1). Apelin is a peptide having a strong homology with 
the angiotensin II type 1 receptor (AT1R) in terms of the 
amino acid sequence (54% in transmembrane domains 
and 30% for the entire sequence) (2) and it is synthesized 
as pre-apelin containing 77 amino acids(3). Pre-apelin 
is transformed into different apelin peptides including 
apelin-12, apelin-13, apelin-17 and apelin-36. Apelin-13 
and apelin-36 are biologically most active forms among 
these peptides (4). Apelin and its receptor APJ are located 
in many organs and systems of the body such as heart, lung, 
brain, kidney, liver, blood vessels, gastrointestinal system 
and adipose tissue (5). This broad distribution suggests 
that the apelin can be involved in many physiological and 
pathological processes (6). Studies showed that the apelin 
/ APJ system has important functions in the cardiovascular 
homeostasis, the regulation of the central and peripheral 
cardiovascular system (7,8). It was found that apelin 
and APJ are expressed in cardiomyocytes and cardiac 
endothelium (9). It is known that apelin / APJ system are 
involved in blood pressure regulation and regulation of 
myocardial contractility (10). It was shown that apelin also 
increases the cardiac inotropic effect (11-15) in addition 
to increasing the vasodilator effect (16). It was detected 
that apelin applied to normal and hypertensive animals 
caused a strong antihypertensive effect (17,18). Since this 
antihypertensive effect is inhibited when administered 
concurrently with the NO synthase inhibitor, it suggests 
that apelin causes vasodilation via a NO-dependent 
mechanism (19). Also in vitro studies, it was shown that 
apelin leads to NO-dependent vasodilation in human 
mesenteric arteries (20). In the light of this information, 
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it is seen that apelin has important effects on the heart 
and circulatory system. However, the number of in vitro 
studies examining its effects on vascular smooth muscle 
contraction is quite small.
Internal mammary artery (IMA) is used frequently as a 
coronary artery bypass graft, because the development 
of atherosclerosis is difficult in IMA, its diameter and flow 
characteristic are proper and rate of obstruction is very 
low compared to the saphenous vein used as a coronary 
bypass graft (21,22).
In the light of the above information, it was stated that apelin 
is vasodilator activity and this activity occurs via NO (19). 
However, there is no study describing the endothelium-
independent activity of IMA on the contraction-relaxation 
mechanism. The main purpose of this study is; The aim of 
this study was to investigate the endothelium independent 
activity of Apelin-13 on the IMA’s contraction-relaxation 
mechanism.
MATERIAL and METHODS
Ethical approval for present study was taken from Firat 
University Faculty of Medicine Clinical Research Ethics 
Committee (Elazig, Turkey), and the informed consents 
were taken from all patients. In the study, the use of human 
IMA segments, which were unused and discarded after 
coronary artery bypass grafting surgery was approved.
Left IMA segments of 13 patients (2 females and 11 males) 
operated at the Cardiovascular Surgery Clinic, were used. 
Demographic characteristics of the patients are shown in 
Table 1.
Table 1. Some clinical features of 13 patients undergoing CABG
Clinical features Mean ± SD, n (%)
Age 64.2 ± 7.0
Weight  70.2 ± 8.0
Body mass index 26.2 ± 2.3
Gender
     Male 11(85)
     Female 2(15)
Smoking 7(54)
Diseases
     Hypertension 7 (55)
     Heart failure 2 (15)
     Diabetes 4 (30)
Medication
     Organic nitrates 0(0)
     Aspirin 8(61)
     Beta-blockers 7(54)
     Calcium channel blockers 3(23)
     Hypolipidaemics 6(46)
     Angiotensin inhibitors 5(38)
The operation material was immediately placed in the 
krebs solution so as not to lose its viability after the 
removal and the experiment was performed by placing it 
in an isolated organ bath in about 20 minutes. The loose 
connective tissues were carefully removed from IMA 
segments and these segments were cut into rings so that 
their length was about 2-3 mm. These prepared tissue 
pieces were placed in an isolated organ bath containing 
Krebs-Henseleit solution (composition in mM: NaCl 118, 
KCl 4.7, MgSO4 1.2, CaCl2 1.25, KH2PO4 1.2, NaHCO3 
25, glucose 11, EDTA 0.03) and the temperature of this 
solution was set to 37° C and the pH was set to 7.4.The 
vessels in the organ bath were continuously ventilated with 
95% oxygen and 5% CO2. The contractile activities of the 
vessels were transferred to the computer via MP150WS 
for Windows (Biopac Systems Inc, CA, ABD) and recorded 
using a physiological force transducer (FDT05, Commat 
Ltd., Ankara, Turkey).
At the beginning of the experiment, the resting tensions of 
the IMA vessels were adjusted to 1 gram, and the vessels 
were kept under this resting tension for 180 minutes to 
adapt to the isolated medium.During this time, the Krebs-
Henseleit solution in the isolated organ bath container 
was changed every 10 minutes.Following the stabilization 
period, cumulative NE (10-9-10-4M) and SNP (10-9-10-
4M) concentrations were applied to the organ bath to 
determine the concentration for the maximum response.
Apelin-13 was obtained from Cayman-Chemical (Cat No: 
13523, Ann Arbor, MI, USA) and NE, SNP and acetylcholine 
chloride from Sigma (St Louis, MO, USA). Each stock 
solution was diluted to the desired concentration just 
prior to administration to the organ bath.
Statistical analysis
Data were expressed as mean ± standard deviation. The 
effect of apelin-13 (10 µM) on contractile activity was 
evaluated using unpaired Student’s T-test. In all statistical 
analyzes, p value < 0.05 was considered to be statistically 
significant.
RESULTS
In present study, the effects of apelin-13 at 10 µM dose 
on the maximum contraction induced by NE (10-9–10-
4M) and the maximum relaxation induced by SNP (10-
9–10-4M) were investigated in human IMA rings.At the 
beginning of the study, we first investigated the effect 
of Apelin-13 at 10 µM dose on basal tension, and in this 
practice, apelin-13 showed no effect on baseline tension 
(data not shown).The dose-dependent contractile activity 
of IMA rings was determined by applying cumulative 
concentrations of NE. After the administration of 
Apelin-13 at a dose of 10 µM, the same protocol was 
reapplied. According to the results, Apelin-13 caused 
significant inhibition on the contractions induced  by  NE 
administration  (10μM,  Figure 1, p < 0.05, n = 13). Apelin-13 
at dose of 10 µM caused statistically significant increase 
in the cumulatively added SNP-induced endothelium-
independent relaxation (10μM, Figure 2, P <0.05, n =13). 
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According to the results, apelin-13 inhibited NE-induced 
IMA contractile activity whereas it facilitated the SNP-
induced endothelium-independent relaxation.
Figure 1. Effects of apelin on norepinephrine induced responses 
(contraction) in human internal mammary artery rings
Figure 2. Effects of apelin on sodium nitroprusside induced 
responses (relaxation) in human internal mammary artery rings
DISCUSSION
In our study, we investigated the effect of Apelin-13 on 
NE-induced contraction and SNP-induced endothelium-
independent relaxation in IMA rings.According to our 
results, apelin-13 inhibited NE-induced IMA contractile 
activity whereas it facilitated the SNP-induced 
endothelium-independent relaxation.Our study is the first 
study showing that Apelin-13 provides a relaxing effect on 
NE-induced contraction of IMA segments isolated from 
human.
IMA rings used in the present study were obtained from 
patients who underwent coronary bypass grafting (CABG) 
surgery due to various cardiovascular diseases as shown 
in Table-1.The SNP-induced endothelium-independent 
relaxation protocol was used as the relaxation protocol 
by taking the possibility of vascular endothelium being 
damaged during the operation into consideration.The 
most commonly used vessels as graft for coronary arteries 
are IMA and saphenous vein. The use of these vessels as 
grafts instead of the heart-feeding blood vessels makes 
the contractile activity in these vessels quite important 
and therefore this topic has become an important research 
area (23).
In previous studies, it was shown that apelin can lead to 
vasoconstriction and vasodilatation on the vasomotor 
system according to the conditions. This double effect 
of apelin is associated to the presence of APJ receptors 
in both endothelium and smooth muscle cell layers 
of the blood vessel wall. Vasoactive agents are said 
to be capable of acting on secretory endothelial cells 
that cause vasoconstriction (eg, endothelin) as well as 
substances that mediate vasodilation on vascular smooth 
muscle cells that cause relaxation (eg, NO, prostacyclin). 
Vasoactive agents can be effective on the substances 
(e.g. NO, prostacyclin) mediating the vasodilatation on 
vascular smooth muscle cells, as well as endothelium 
cells producing secretions that cause vasoconstriction 
(e.g. endothelin) (24). In a previous study, it was shown 
that Apelin-13 has vasodilator activity on IMA (25). 
However, the vasodilator effect in this study was based 
on endothelium-dependent NO-induced mechanisms. It 
was said that vasodilator effect was lost in groups with 
endothelial damage. However, practice with SNP showing 
endothelium-independent relaxation was not performed. 
The degree of endothelium damage and whether all 
endothelium was affected were unclear. In addition, 
there was no data about the additional diseases and 
the drugs of the individuals included in the experimental 
group. It is unclear whether the results in this study were 
due to the effects of the drugs used by the patient or if 
it is due to apelin. However, in our study, the IMA strips 
were washed for 180 minutes instead of the standard 
120 minutes and the effects of the drugs and anesthesia 
used by the individuals were eliminated. SNP having 
endothelium-independent effect was used to put forward 
the endothelium-independent effect clearly.
As a result, the findings obtained from our study showed 
that apelin-13 has the inhibitory activity on NE-induced 
contractions and the facilitative activity on SNP-induced 
endothelium-independent relaxation in human IMA. In the 
light of these information, Apelin-13 shows its relaxation 
effect on IMA contractile activity with not only endothelium-
dependent NO mechanisms but also by facilitating SNP-
induced endothelium-independent relaxation. Because of 
this, not only endothelium-dependent but also endothelium 
independent mechanisms plays a role in the occurrence 
of apelin-13 vasodilator effect. Similarly, in most of 
the studies showing the vasodilator activity of apelin, 
vasodilation mechanisms were based on cGMP-mediated 
NO pathways (20,26,27). For the first time with our study, it 
was shown that endothelium-independent pathways were 
also effective under the vasodilator mechanism except for 
endothelium-dependent NO. 
Coronary bypass surgery is an important treatment option 
in patients with coronary artery disease. The use of IMA as 
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a graft instead of the coronary artery increased the number 
of the studies about the contractile activity in the IMA and 
hormonal or pharmacological agents that may affect this. 
Apelin is a hormone that has effects in many systems 
but has significant effects in the cardiovascular system. 
Previous studies have demonstrated its efficacy on many 
vessel contractile activities in both experimental animals 
and humans. However, previous studies suggested 
that the vasodilator activity of apelin depend on cGMP-
associated endothelium-dependent NO mechanisms. In 
addition, these previous studies showed that apelin does 
not have an endothelium-independent activity on the 
vessel or cause vasoconstriction in the case of endothelial 
damage. However, our study is important since it is the 
first study showing that apelin-13 leads to endothelium-
independent vasodilation on human IMA. Our study, which 
demonstrates the presence of endothelium-independent 
activity of Apelin-13, is a pioneering study in order to clarify 
the endothelium-independent mechanisms of apelin-13. 
Further studies are needed to reveal the molecular 
mechanisms underlying endothelium-independent effect. 
CONCLUSION
In conclusion, while apelin-13 facilitates SNP-induced 
endothelium-independent relaxation in human IMA, it 
causes inhibition on NE-induced contractions.
Competing interests: The authors declare that they have no competing 
interest. 
Financial Disclosure: There are no financial supports 
Ethical approval: Ethical approval for present study was taken from Firat 
University Faculty of Medicine Clinical Research Ethics Committee 
Emine kacar ORCID: 0000-0002-1585-7248
Oktay Burma [oburma@firat.edu.tr] {ORCID:0000-0002-0880-4578
Ihsan Serhatlioglu ORCID: 0000-0002-2384-7971
Nazife Ulker ORCID: 0000-0002-3805-2362
Ahmet Yardimci ORCID: 0000-0001-5740-9518
Ayhan Uysal ORCID: 0000-0001-7526-5554
Haluk Kelestimur ORCID: 0000-0001-9971-5716
REFERENCES
1. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and 
characterization of a novel endogenous peptide ligand for 
the human APJ receptor. Biochem Biophys Res Commun 
1998;251:471-6.
2. Lu L, Wu D, Li L, et al. Apelin/APJ system: A bifunctional target 
for cardiac hypertrophy. Int J Cardiol 2017;230:164-70. 
3. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological 
and immunohistochemical characterization of the APJ 
receptor and its endogenous ligand apelin. J Neurochem 
2003;84:1162-72. 
4. Huang Z, Wu L, Chen L. Apelin/APJ system: A novel 
potential therapy target for kidney disease. J Cell Physiol 
2018;233:3892-900.
5. Kawamata Y, Habata Y, Fukusumi S, et al. Molecular 
properties of apelin: tissue distribution and receptor binding. 
Biochim Biophys Acta 2001;1538:162-71.
6. Liu J, Liu M, Chen L. Novel pathogenesis: regulation of 
apoptosis by Apelin/APJ system. Acta Biochimt Biophys Sin 
(Shanghai) 2017;49:471-8.
7. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, 
the ligand for the APJ receptor. J Neurochem 2000;74:34-41.
8. Masri B, Knibiehler B, Audigier Y. Apelin signalling: a 
promising pathway from cloning to pharmacology. Cell 
Signal 2005;17:415-26.
9. Yamaleyeva LM, Shaltout HA, Varagic J. Apelin-13 in blood 
pressure regulation and cardiovascular disease. Curr Opin 
Nephrol Hypertens 2016;25:396-403.
10. Rostamzadeh F, Najafipour H, Yeganeh-Hajahmadi M, 
et al. Heterodimerization of apelin and opioid receptors 
and cardiac inotropic and lusitropic effects of apelin in 
2K1C hypertension: Role of pERK1/2 and PKC. Life Sci 
2017;191:24-33.
11. Dai T, Ramirez-Correa G, Gao WD. Apelin increases 
contractility in failing cardiac muscle. Eur J Pharmacol 
2006;553:222-8.
12. Chun HJ, Ali ZA, Kojima Y, et al. Apelin signaling antagonizes 
Ang II effects in mouse models of atherosclerosis. J Clin 
Invest 2008;118:3343-54.
13. Hashimoto T, Kihara M, Imai N, et al. Requirement of 
apelin-apelin receptor system for oxidative stress-linked 
atherosclerosis. Am J Pathol 2007;171:1705-12.
14. Li F, Li L, Qin X, et al. Apelin-induced vascular smooth 
muscle cell proliferation: the regulation of cyclin D1. Front 
Biosci 2008;13:3786-92.
15. Yu XH, Tang ZB, Liu LJ, et al. Apelin and its receptor APJ in 
cardiovascular diseases. Clin Chim Acta 2014;428:1-8. 
16. Reaux A, De Mota N, Skultetyova I, et al. Physiological role of 
a novel neuropeptide, apelin, and its receptor in the rat brain. 
J Neurochem 2001;77:1085-96. 
17. Katugampola SD, MacGuire JJ, Mathewson SR, et al. 
(125I)-(Pyr1)Apelin-13 is a novel radioligand for localizing 
the APJ orphan receptor in human and rat tissues with 
evidence for a vasoconstrictor role in man. Br J Pharmacol 
2001;132:1255-60.
18. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric 
Oxide 2001;5:88-97.
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